ArticleMedComm2025

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Sehwa Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.